Management for reducing medication discrepancy and efficacy evaluation in ACS patients during the transition from hospital to home

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
INTERVENTION: Control group:Conventional treatment and nursing;Trial group:Conventional treatment and nursing + Medication discrepancy management based on medication reconciliation process; CONDITION: Acute coronary syndrome PRIMARY OUTCOME: Incidence of medication discrepancies; SECONDARY OUTCOME: Adverse events;Medication adherence;Unplanned readmission rate; INCLUSION CRITERIA: 1.First diagnosed with ACS, meeting the diagnostic criteria of the Emergency Rapid Diagnosis and Treatment Guidelines for Acute Coronary Syndrome (2019), and undergoing PCI; 2.Patients on polypharmacy, defined as using at least 5 long‐term prescription medications after discharge; 3.Patients with the ability to communicate and who provided informed consent for this study;
Epistemonikos ID: 39b927236242da910ea38c1496b2a95c4002a63e
First added on: Sep 12, 2026